EP1485497A4 - Ricin-impfstoff und verfahren zur herstellung und verwendung davon - Google Patents

Ricin-impfstoff und verfahren zur herstellung und verwendung davon

Info

Publication number
EP1485497A4
EP1485497A4 EP02721157A EP02721157A EP1485497A4 EP 1485497 A4 EP1485497 A4 EP 1485497A4 EP 02721157 A EP02721157 A EP 02721157A EP 02721157 A EP02721157 A EP 02721157A EP 1485497 A4 EP1485497 A4 EP 1485497A4
Authority
EP
European Patent Office
Prior art keywords
making
methods
ricin vaccine
ricin
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02721157A
Other languages
English (en)
French (fr)
Other versions
EP1485497A2 (de
Inventor
Mark A Olson
Charles B Millard
Michael P Byrne
Robert W Wannemacher
Ross D Leclaire
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Army Medical Research and Materiel Command USAMRMC
Original Assignee
US Army Medical Research and Materiel Command USAMRMC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Army Medical Research and Materiel Command USAMRMC filed Critical US Army Medical Research and Materiel Command USAMRMC
Publication of EP1485497A2 publication Critical patent/EP1485497A2/de
Publication of EP1485497A4 publication Critical patent/EP1485497A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Botany (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP02721157A 2002-02-27 2002-02-27 Ricin-impfstoff und verfahren zur herstellung und verwendung davon Withdrawn EP1485497A4 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2002/005732 WO2003072018A2 (en) 2002-02-27 2002-02-27 Ricin vaccine and methods of making and using thereof

Publications (2)

Publication Number Publication Date
EP1485497A2 EP1485497A2 (de) 2004-12-15
EP1485497A4 true EP1485497A4 (de) 2005-07-27

Family

ID=27765157

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02721157A Withdrawn EP1485497A4 (de) 2002-02-27 2002-02-27 Ricin-impfstoff und verfahren zur herstellung und verwendung davon

Country Status (4)

Country Link
EP (1) EP1485497A4 (de)
AU (1) AU2002252102A1 (de)
CA (1) CA2477094A1 (de)
WO (1) WO2003072018A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9133253B2 (en) * 2010-04-22 2015-09-15 The United States Of America As Represented By The Secretary Of The Army Ricin vaccine and methods of making thereof
US10233256B2 (en) 2014-11-28 2019-03-19 The Israel Institute of Biological Research (IIBR) Antibodies directed to ricin toxin
US10208108B2 (en) 2014-11-28 2019-02-19 The Israel Institute of Biological Research (IIBR) Antibodies directed to ricin toxin

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988009344A1 (en) * 1987-05-21 1988-12-01 Creative Biomolecules, Inc. Targeted multifunctional proteins
US5626844A (en) * 1991-11-04 1997-05-06 The United States Of America As Represented By The Secretary Of The Army Monoclonal antibody against ricin A chain

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6333303B1 (en) * 1996-04-30 2001-12-25 Twinstrand Therapeutics Inc. Antiviral ricin-like proteins
US6531125B1 (en) * 1999-03-02 2003-03-11 Twinstrand Therapeutics Inc. Antiviral ricin-like proteins

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988009344A1 (en) * 1987-05-21 1988-12-01 Creative Biomolecules, Inc. Targeted multifunctional proteins
US5626844A (en) * 1991-11-04 1997-05-06 The United States Of America As Represented By The Secretary Of The Army Monoclonal antibody against ricin A chain

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HEWETSON J F ET AL: "PROTECTION OF MICE FROM INHALED RICIN BY VACCINATION WITH RICIN OR BY PASSIVE TREATMENT WITH HETEROLOGOUS ANTIBODY", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, vol. 11, no. 7, May 1993 (1993-05-01), pages 743 - 746, XP000943703, ISSN: 0264-410X *
LEMLEY P V ET AL: "IDENTIFICATION AND CHARACTERIZATION OF A MONOCLONAL ANTIBODY THAT NEUTRALIZES RICIN TOXICITY IN VITRO AND IN VIVO", HYBRIDOMA, LIEBERT, NEW YORK, NY, US, vol. 13, no. 5, October 1994 (1994-10-01), pages 417 - 421, XP000943688, ISSN: 0272-457X *

Also Published As

Publication number Publication date
WO2003072018A2 (en) 2003-09-04
CA2477094A1 (en) 2003-09-04
EP1485497A2 (de) 2004-12-15
AU2002252102A1 (en) 2003-09-09
WO2003072018A3 (en) 2004-01-29

Similar Documents

Publication Publication Date Title
IL176089A0 (en) Modified macromolecules and methods of making and using thereof
EP1551376A4 (de) Immunomodulatorische zusammensetzungen, herstellungsverfahren und verwendungsverfahren dafür
ZA200305825B (en) Modified antibodies and methods of use
PL375691A1 (en) Imidazolopyridines and methods of making and using the same
EP1549756A4 (de) Rekombinante mutanten von rhabdovirus und verfahren zur verwendung davon
EP1465615A4 (de) Trizyklische bisenon-derivate und verfahren zu ihrer verwendung
AU2003217870A8 (en) Pini-modulating compounds and methods of use thereof
IL169648A0 (en) Novel structures and method of preparation
IL164703A0 (en) ImidazoÄ1,2-AÜpyrazin-8-ylamines method of making and method of use thereof
EP1567099A4 (de) Verbesserteendoprothesen und verfahren zu ihrer herstellung
AU2003213673A8 (en) Pin1-modulating compounds and methods of use thereof
EP1639086A4 (de) Rna-interferasen und verfahren zur verwendung davon
EP1476150A4 (de) Carboxyfullerene und verwendungsverfahren dafür
AU2003269444A8 (en) An improved pacifier and method of use thereof
EP1496110A4 (de) Verfahren zur vermehrung menschlicher hepatozyten und verfahren zur gewinnung menschlicher hepatozyten
AU2003299441A8 (en) Nf-hev compositions and methods of use
EP1613338A4 (de) Tamandarin-analoga und fragmente davon und herstellungs- und anwendungsverfahren dafür
AU2002346548A8 (en) Regioisomerically pure oxochlorins and methods of synthesis
EP1497654A4 (de) Immunoglobulin-e-vakzine und verwendungsverfahren dafür
EP1663255A4 (de) Withanamid und withanolid-zusammensetzungen und anwendungsverfahren dafür
GB0303609D0 (en) Novel therapeutic method and compositions
GB2401094B (en) Labels and methods of manufacture thereof
AU2003239868A8 (en) Sunscreen compositions and methods of use thereof
EP1491091A4 (de) Mittel zum schutz gegen insekten und verfahren zum schützen gegen insekten
EP1625141A4 (de) Zusammensetzungen auf basis von grp94 und verfahren zu deren anwendung

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20040920

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

A4 Supplementary search report drawn up and despatched

Effective date: 20050613

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 38/43 20060101ALI20070222BHEP

Ipc: C12N 15/52 20060101ALI20070222BHEP

Ipc: C12N 9/38 20060101ALI20070222BHEP

Ipc: C12N 9/26 20060101ALI20070222BHEP

Ipc: C12N 9/24 20060101ALI20070222BHEP

Ipc: C12N 9/00 20060101AFI20070222BHEP

RTI1 Title (correction)

Free format text: RICIN DERIVATIVES AND VACCINES BASED THEREON

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070901